Expert Panel Criticizes WHO, China for Pandemic Response
TUESDAY, Jan. 19, 2021 -- China should have done more to fight the COVID-19 pandemic in the early stages, according to a panel of experts commissioned by the World Health Organization.
"What is clear to the panel is that public health measures could have been applied more forcefully by local and national health authorities in China in January," the panel said in a report released to the media Monday, the Associated Press reported. There were "lost opportunities" to establish basic public health measures early in the pandemic.
The panel, led by former Liberian President Ellen Johnson Sirleaf and former New Zealand Prime Minister Helen Clark, also questioned whether the WHO should have labeled the situation a pandemic sooner, the AP reported. However, the WHO is constrained by a lack of funding and "has no powers to enforce anything," Johnson Sirleaf noted at a press briefing on Tuesday. "All it can do is ask to be invited in."
Countries need to decide whether to give WHO more authority to combat outbreaks, Johnson Sirleaf said, the AP reported.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
Read this next
TUESDAY, March 2, 2021 -- Individuals with previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection generate strong responses to one dose of the BNT162b2...
TUESDAY, March 2, 2021 -- Treatment with interleukin-6 receptor antagonists tocilizumab and sarilumab improves outcomes among critically ill patients with COVID-19 receiving organ...
MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.